Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care
2022 · The Lancet Respiratory Medicine · 54 citations
https://doi.org/10.1016/s2213-2600(22)00412-x